Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000891293-21-000045)

Filing Details

Accession Number:: 0000891293-21-000045
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-02 17:16:07
Reporting Period:: 2021-06-30

Accepted Time:: 2021-12-02 17:16:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
891293	Cti Biopharma Corp	CTIC	Pharmaceutical Preparations (2834)	911533912

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1339498	R Adam Craig	3101 Western Avenue Suite 800 Seattle WA 98121	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-06-30	5,000	$2.13	10,000	No	4	A	Direct
Common Stock	Acquisiton	2021-12-02	1,322	$1.52	11,322	No	4	P	Direct
Common Stock	Acquisiton	2021-12-02	2,178	$1.53	13,500	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan.